The farnesyltransferase inhibitor R115777 (tipifarnib) in combination with tamoxifen acts synergistically to inhibit MCF-7 breast cancer cell proliferation and cell cycle progression<i>in vitro</i>and<i>in vivo</i>
Molecular cancer therapeutics